Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Effects of nicotine nasal spray on cognitive function in schizophrenia.

Smith RC, Warner-Cohen J, Matute M, Butler E, Kelly E, Vaidhyanathaswamy S, Khan A.

Neuropsychopharmacology. 2006 Mar;31(3):637-43.

2.

Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia.

Smith RC, Singh A, Infante M, Khandat A, Kloos A.

Neuropsychopharmacology. 2002 Sep;27(3):479-97.

3.

Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray.

Myers CS, Taylor RC, Moolchan ET, Heishman SJ.

Neuropsychopharmacology. 2008 Feb;33(3):588-98. Epub 2007 Apr 18.

4.

[A review of the effects of nicotine on schizophrenia].

Bidzan L.

Psychiatr Pol. 2007 Sep-Oct;41(5):737-44. Review. Polish.

PMID:
18421928
5.

The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls.

Barr RS, Culhane MA, Jubelt LE, Mufti RS, Dyer MA, Weiss AP, Deckersbach T, Kelly JF, Freudenreich O, Goff DC, Evins AE.

Neuropsychopharmacology. 2008 Feb;33(3):480-90. Epub 2007 Apr 18.

6.

The nicotinergic receptor as a target for cognitive enhancement in schizophrenia: barking up the wrong tree?

Quisenaerts C, Morrens M, Hulstijn W, de Bruijn E, Timmers M, Streffer J, De la Asuncion J, Dumont G, Sabbe B.

Psychopharmacology (Berl). 2014 Feb;231(3):543-50.

PMID:
24022237
7.

Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder.

Hong LE, Thaker GK, McMahon RP, Summerfelt A, Rachbeisel J, Fuller RL, Wonodi I, Buchanan RW, Myers C, Heishman SJ, Yang J, Nye A.

Arch Gen Psychiatry. 2011 Dec;68(12):1195-206. doi: 10.1001/archgenpsychiatry.2011.83. Epub 2011 Aug 1.

8.

Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits.

Poltavski DV, Petros T.

Physiol Behav. 2006 Mar 30;87(3):614-24. Epub 2006 Feb 7.

PMID:
16466655
9.

Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms.

Sacco KA, Termine A, Seyal A, Dudas MM, Vessicchio JC, Krishnan-Sarin S, Jatlow PI, Wexler BE, George TP.

Arch Gen Psychiatry. 2005 Jun;62(6):649-59.

PMID:
15939842
10.

Nicotine-haloperidol interactions and cognitive performance in schizophrenics.

Levin ED, Wilson W, Rose JE, McEvoy J.

Neuropsychopharmacology. 1996 Nov;15(5):429-36.

11.

Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.

Atzori G, Lemmonds CA, Kotler ML, Durcan MJ, Boyle J.

J Clin Psychopharmacol. 2008 Dec;28(6):667-74. doi: 10.1097/JCP.0b013e31818c9bb8.

PMID:
19011436
12.

Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder.

Smith RC, Lindenmayer JP, Davis JM, Cornwell J, Noth K, Gupta S, Sershen H, Lajtha A.

Schizophr Res. 2009 May;110(1-3):149-55. doi: 10.1016/j.schres.2009.02.001. Epub 2009 Feb 28.

PMID:
19251401
13.

Effects of transdermal nicotine on prose memory and attention in smokers and nonsmokers.

Poltavski DV, Petros T.

Physiol Behav. 2005 Jan 17;83(5):833-43. Epub 2004 Nov 23.

PMID:
15639169
14.

Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized Trial.

Smith RC, Amiaz R, Si TM, Maayan L, Jin H, Boules S, Sershen H, Li C, Ren J, Liu Y, Youseff M, Lajtha A, Guidotti A, Weiser M, Davis JM.

PLoS One. 2016 Jan 5;11(1):e0143490. doi: 10.1371/journal.pone.0143490. eCollection 2016.

15.

Double dissociation of working memory and attentional processes in smokers and non-smokers with and without nicotine.

Grundey J, Amu R, Ambrus GG, Batsikadze G, Paulus W, Nitsche MA.

Psychopharmacology (Berl). 2015 Jul;232(14):2491-501. doi: 10.1007/s00213-015-3880-7. Epub 2015 Feb 27.

PMID:
25721074
16.

Effects of high dose transdermal nicotine replacement in cigarette smokers.

Hatsukami D, Mooney M, Murphy S, LeSage M, Babb D, Hecht S.

Pharmacol Biochem Behav. 2007 Jan;86(1):132-9. Epub 2007 Jan 4.

17.

The effects of nicotine in dermal plaster on cognitive functions in patients with Alzheimer's disease.

Snaedal J, Johannesson T, Jonsson JE, Gylfadottir G.

Dementia. 1996 Jan-Feb;7(1):47-52.

PMID:
8788082
18.

Do adolescent smokers experience withdrawal effects when deprived of nicotine?

Killen JD, Ammerman S, Rojas N, Varady J, Haydel F, Robinson TN.

Exp Clin Psychopharmacol. 2001 May;9(2):176-82.

PMID:
11518093
19.

A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.

Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC.

J Clin Psychopharmacol. 2007 Aug;27(4):380-6.

PMID:
17632223
20.

Effects of smoking abstinence on visuospatial working memory function in schizophrenia.

George TP, Vessicchio JC, Termine A, Sahady DM, Head CA, Pepper WT, Kosten TR, Wexler BE.

Neuropsychopharmacology. 2002 Jan;26(1):75-85.

Supplemental Content

Support Center